Patient perspective on antifibrotic monitoring - impact on management at a single UK prescribing centre
S. Hussain (Oxford, United Kingdom), C. Ruggiero (Oxford, United Kingdom), K. Parsons (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), R. Luqmani (Oxford, United Kingdom), V. Nathwani (Oxford, United Kingdom), S. Zulfikar (Oxford, United Kingdom), E. Fraser (Oxford, United Kingdom), P. Saunders (Oxford, United Kingdom), L. Ho (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom)
Source: International Congress 2022 – Nursing interventions in various respiratory areas
Session: Nursing interventions in various respiratory areas
Session type: Thematic Poster
Number: 4020
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hussain (Oxford, United Kingdom), C. Ruggiero (Oxford, United Kingdom), K. Parsons (Oxford, United Kingdom), S. Poole (Oxford, United Kingdom), R. Luqmani (Oxford, United Kingdom), V. Nathwani (Oxford, United Kingdom), S. Zulfikar (Oxford, United Kingdom), E. Fraser (Oxford, United Kingdom), P. Saunders (Oxford, United Kingdom), L. Ho (Oxford, United Kingdom), R. Hoyles (Oxford, United Kingdom). Patient perspective on antifibrotic monitoring - impact on management at a single UK prescribing centre. 4020
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|